Abstract
The Hordaland Homocysteine Study is a population-based screening of total plasma homocysteine (tHcy) in ∼18,000 men and women aged 40–67 yr that took place in 1992–1993 in the county of Hordaland in Western Norway. In this cohort, tHcy was associated with several physiologic and life-style factors, including age and gender, blood pressure, serum cholesterol, smoking, alcohol and coffe consumption, physical activity, diet, and vitamin status. All associations with established cardiovascular risk factors were in the direction expected to confer increased risk. In a subset of 5,883 women aged 40–42 yr, tHcy was associated with previous pregnancy outcomes, including preeclampsia, placental abruption, and neural tube defects. This article reviews the published results from the Hordaland Homocysteine Study in the light of relevant literature. The Hordaland Homocysteine cohort will be used for future investigations of the stability of tHcy and vitamin status over time, and to investigate associations with mortality and morbidity including cancer incidence.
Similar content being viewed by others
Abbreviations
- CVD:
-
cardiovascular disease
- HPLC:
-
high-performance liquid chromatography
- MTHFR:
-
methylenetetrahydrofolate reductase
- tCys:
-
total cysteine
- tHcy:
-
total homocysteine
References
Fiskerstrand, T., Refsum, H., Kvalheim, G., and Ueland, P.M. (1993) Homocysteine and Other Thiols in Plasma and Urine: Automated Determination and Sample Stability, Clin. Chem. 39, 263–271.
Nygård, O., Vollset, S.E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J.E., Ueland, P.M., and Kvåle, G. (1995) Total Plasma Homocysteine and Cardiovascular Risk Profile. The Hordaland Homocysteine Study, J. Am. Med. Assoc. 274, 1526–1533.
Jacques, P.F., Rosenberg, I.H., Rogers, G., Selhub, J., Bowman, B.A., Gunter, E.W., Wright, J.D., and Johnson, C.L. (1999) Serum Total Homocysteine Concentrations in Adolescent and Adult Americans: Results from the Third National Health and Nutrition Examination Survey, Am. J. Clin. Nutr. 69, 482–489.
Selhub, J., Jacques, P.F., Rosenberg, I.H., Rogers, G., Bowman, B.A., Gunter, E.W., Wright, J.D., and Johnson, C.L. (1999) Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (1991–1994): Population Reference Ranges and Contribution of Vitamin Status of High Serum Concentrations, Ann. Intern. Med. 131, 331–339.
Ueland, P.M., Refsum, H., and Schneede, J. (2000) Determinants of Plasma Homocysteine, in Homocysteine and Vascular Disease (Robinson, K., ed.) pp. 59–84, Kluwer Academic Publishers, Dordrecht.
Arnesen, E., Refsum, H., Bønaa, K.H., Ueland, P.M., Förde, O.H., and Nordrehaug, J.E. (1995) Serum Total Homocysteine and Coronary Heart Disease, Int. J. Epidemiol. 24, 704–709.
Pancharuniti, N., Lewis, C.A., Sauberlich, H.E., Perkins, L.L., Go, R.C., Alvarez, J.O., Macaluso, M., Acton, R.T., Copeland, R.B., Cousins, A.L., et al. (1994) Plasma Homocyst(e)ine, Folate, and Vitamin B-12 Concentrations and Risk for Early-Onset Coronary Artery Disease, Am. J. Clin. Nutr. 59, 940–948.
Refsum, H., Ueland, P.M., Nygård, O., and Vollset, S.E. (1998) Homocysteine and Cardiovascular Disease, Annu. Rev. Med. 49, 31–62.
Lien, E.A., Nedrebo, B.G., Varhaug, J.E., Nygård, O., Aakvaag, A., and Ueland, P.M. (2000) Plasma Total Homocysteine Levels During Short-Term Iatrogenic Hypothyroidism, J. Clin. Endocrinol. Metab. 85, 1049–1053.
Brattström, L., Lindgren, A., Israelsson, B., Andersson, A., and Hultberg, B. (1994) Homocysteine and Cysteine: Determinants of Plasma Levels in Middle-Aged and Elderly Subjects, J. Intern. Med. 236, 633–641.
Lussier-Cacan, S., Xhignesse, M., Piolot, A., Selhub, J., Davignon, J., and Genest, J. (1996) Plasma Total Homocysteine in Healthy Subjects: Sex-Specific Relation with Biological Traits, Am. J. Clin. Nutr. 64, 587–593.
Rasmussen, L.B., Ovesen, L., Bulow, I., Knudsen, N., Laurberg, P., and Perrild, H. (2000) Folate Intake, Lifestyle Factors, and Homocysteine Concentrations in Younger and Older Women, Am. J. Clin. Nutr. 72, 1156–1163.
Vollset, S.E., Refsum, H., Nygård, O., and Ueland, P.M. (2001) Lifestyle Factors Associated with Hyperhomocysteinemia, in Homocysteine in Health and Disease (Carmel, R., and Jacobsen, D.W., eds.) Cambridge University Press, Cambridge.
Nygård, O., Refsum, H., Ueland, P.M., and Vollset, S.E. (1998) Major Lifestyle Determinants of Plasma Total Homocysteine Distribution: The Hordaland Homocysteine Study, Am. J. Clin. Nutr. 67, 263–270.
Bergmark, C., Mansoor, M.A., Swedenborg, J., de Faire, U., Svardal, A.M., and Ueland, P.M. (1993) Hyperhomocysteinemia in Patients Operated for Lower Extremity Ischaemia Below the Age of 50. Effect of Smoking and Extent of Disease, Eur. J. Vasc. Surg. 7, 391–396.
Wu, L.L., Wu, J., Hunt, S.C., James, B.C., Vincent, G.M., Williams, R.R., and Hopkins, P.N. (1994) Plasma Homocyst(e)ine as a Risk Factor for Early Familial Coronary Artery Disease, Clin. Chem. 40, 552–561.
Mansoor, A.M., Bergmark, C., Svardal, A.M., Lønning, P.E., and Ueland, P.M. (1995) Redox Status and Protein-Binding of Plasma Homocysteine and Other Aminothiols in Patients with Early-Onset Peripheral Vascular Disease, Arterioscler. Thromb. Vasc. Biol. 15, 232–240.
Ueland, P.M., Refsum, H., and Brattström, L. (1992) Plasma Homocysteine and Cardiovascular Disease, in Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function (Francis, R.B., Jr., ed.) pp. 183–236, Marcel Dekker, New York.
Vollset, S.E., Nygård, O., Kvåle, G., Ueland, P.M., and Refsum, H. (1997) The Hordaland Homocysteine Study: Lifestyle and Total Plasma Homocysteine in Western Norway, in Homocysteine Metabolism. From Basic Science to Clinical Medicine (Graham, I., Refsum, H., Rosenberg, I.H., and Ueland, P.M., eds.) pp. 177–182, Kluwer Academic Publisher, Dordrecht.
Bleich, S., Degner, D., Wiltfang, J., Maler, J.M., Niedmann, P., Cohrs, S., Mangholz, A., Porzig, J., Sprung, R., Ruther, E., and Kornhuber, J. (2000) Elevated Homocysteine Levels in Alcohol Withdrawal, Alcohol 35, 351–354.
Ubbink, J.B., Fehily, A.M., Pickering, J., Elwood, P.C., and Vermaak, W.J. (1998) Homocysteine and Ischaemic Heart Disease in the Caerphilly Cohort, Atherosclerosis 140, 349–356.
van der Gaag, M.S., Ubbink, J.B., Sillanaukee, P., Nikkari, S., and Hendriks, H.F. (2000) Effect of Consumption of Red Wine, Spirits, and Beer on Serum Homocysteine [Letter], Lancet 355, 1522.
Gudnason, V., Stansbie, D., Scott, J., Bowron, A., Nicaud, V., and Humphries, S. (1998) C677T (Thermolabile Alanine/Valine) Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR): Its Frequency and Impact on Plasma Homocysteine Concentration in Different European Populations. EARS Group, Atherosclerosis 136, 347–354.
Wright, M., Francis, K., and Cornwell, P. (1998) Effect of Acute Exercise on Plasma Homocysteine, J. Sports Med. Phys. Fitness 38, 262–265.
De Cree, C., Malinow, M.R., van Kranenburg, G.P., Geurten, P.G., Longford, N.T., and Keizer, H.A. (1999) Influence of Exercise and Menstrual Cycle Phase on Plasma Homocyst(e)ine Levels in Young Women—a Prospective Study, Scand. J. Med. Sci. Sports 9, 272–278.
Nygård, O., Refsum, H., Ueland, P.M., Stensvold, I., Nordrehaug, J.E., Kvåle, G., and Vollset, S.E. (1997) Coffee Consumption and Total Plasma Homocysteine. The Hordaland Homocysteine Study, Am. J. Clin. Nutr. 65, 136–143.
Stolzenberg-Solomon, R.Z., Miller, E.R., 3rd, Maguire, M.G., Selhub, J., and Appel, L.J. (1999) Association of Dietary Protein Intake and Coffee Consumption with Serum Homocysteine Concentrations in an Older Population, Am. J. Clin. Nutr. 69, 467–475.
Jacques, P.F., Bostom, A.G., Wilson, P.W.F., Rich, S., Rosenberg, I.H., and Selhub, J. (2001) Determinants of Plasma Total Homocysteine Concentration in the Framingham Offspring Cohort, Am. J. Clin. Nutr. 73, 613–621.
Nieto, F.J., Comstock, G.W., Chambless, L.E., and Malinow, R.M. (1997) Coffee Consumption and Plasma Homocyst(e)ine: Results from the Atherosclerosis Risk in Communities Study, Am. J. Clin. Nutr. 66, 1475–1477.
Grubben, M.J., Boers, G.H., Blom, H.J., Broekhuizen, R., de Jong, R., van Rijt, L., de Ruijter, E., Swinkels, D.W., Nagengast, F.M., and Katan, M.B. (2000) Unfiltered Coffee Increases Plasma Homocysteine Concentrations in Healthy Volunteers: A Randomized Trial, Am. J. Clin. Nutr. 71, 480–484.
Urgert, R., van Vliet, T., Zock, P.L., and Katan, M.B. (2000) Heavy Coffee Consumption and Plasma Homocysteine: A Randomized Controlled Trial in Healthy Volunteers, Am. J. Clin. Nutr. 72, 1107–1110.
Allen, R.H., Stabler, S.P., Savage, D.G., and Lindenbaum, J. (1994) Metabolic Abnormalities in Cobalamin (Vitamin-B 12) and Folate Deficiency, FASEB J. 7, 1344–1353.
Brattström, L., Landgren, F., Israelsson, B., Lindgren, A., Hultberg, B., Andersson, A., Cuskelly, G., McNulty, H., Strain, S.S., McPartlin, J., et al. (1998) Lowering Blood Homocysteine with Folic Acid Based Supplements: Meta-analysis of Randomised Trials, Br. Med. J. 316, 894–898.
van der Griend, R., Biesma, D.H., Haas, F.J., Faber, J.A., Duran, M., Meuwissen, O.J., and Banga, J.D. (2000) The Effect of Different Treatment Regimens in Reducing Fasting and Postmethionine-load Homocysteine Concentrations, J. Intern. Med. 248, 223–229.
McKinley, M.C., McNulty, H., McPartlin, J., Strain, J.J., Pentieva, K., Ward, M., Weir, D.G., and Scott, J.M. (2001) Low Dose Vitamin B6 Effectively Lowers Fasting Plasma Homocysteine in Healthy Elderly People Who Are Folate and Riboflavin Replete, Am. J. Clin. Nutr. 73, 759–764.
Selhub, J., Jacques, P.F., Wilson, P.W.F., Rush, D., and Rosenberg, I.H. (1993) Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population, J. Am. Med. Assoc. 270, 2693–2698.
Guttormsen, A.B., Ueland, P.M., Nesthus, I., Nygård, O., Schneede, J., Vollset, S.E., and Refsum, H. (1996) Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia (≥40 μmol/liter). The Hordaland Homocysteine Study, J. Clin. Investig. 98, 2174–2183.
Ueland, P.M., Hustad, S., Schneede, J., Refsum, H., and Vollset, S.E. (2001) Biological and Clinical Implications of the MTHFR C677T Polymorphism, Trends Pharmacol. Sci. 22, 195–201.
Hustad, S., Ueland, P.M., Vollset, S.E., Zhang, Y., Bjorke-Monsen, A.L., and Schneede, J. (2000) Riboflavin as a Determinant of Plasma Total Homocysteine: Effect Modification by the Methylenetetrahydrofolate Reductase C677T Polymorphism, Clin. Chem. 46, 1065–1071.
El-Khairy, L., Ueland, P.M., Nygård, O., Refsum, H., and Vollset, S.E. (1999) Lifestyle and Cardiovascular Disease Risk Factors as Determinants of Total Cysteine in Plasma: The Hordaland Homocysteine Study, Am. J. Clin. Nutr. 70, 1016–1024.
van den Brandhof, W.E., Haks, K., Schouten, E.G., and Verhoef, P. (2001) The Relation Between Plasma Cysteine, Plasma Homocysteine and Coronary Atherosclerosis, Atherosclerosis 157, 403–409.
Araki, A., Sako, Y., Fukushima, Y., Matsumoto, M., Asada, T., and Kita, T. (1989) Plasma Sulfhydryl-Containing Amino Acids in Patients with Cerebral Infarction and in Hypertensive Subjects, Atherosclerosis 79, 139–146.
Mills, B.J., Weiss, M.M., Lang, C.A., Liu, M.C., and Ziegler, C. (2000) Blood Glutathione and Cysteine Changes in Cardiovascular Disease, J. Lab. Clin. Med. 135, 396–401.
Ueland, P.M. (1995) Homocysteine Species as Components of Plasma Redox Thiol Status, Clin. Chem. 41, 340–342.
Vollset, S.E., Refsum, H., Irgens, L.M., Emblem, B.M., Tverdal, A., Gjessing, H.K., Monsen, A.L., and Ueland, P.M. (2000) Plasma Total Homocysteine, Pregnancy Complications, and Adverse Pregnancy Outcomes: the Hordaland Homocysteine Study, Am. J. Clin. Nutr. 71, 962–968.
Ray, J.G., and Laskin, C.A. (1999) Folic Acid and Homocyst(e)ine Metabolic Defects and the Risk of Placental Abruption, Pre-Eclampsia and Spontaneous Pregnancy Loss: A Systematic Review, Placenta 20, 519–529.
Scholl, T.O., and Johnson, W.G. (2000) Folic Acid: Influence on the Outcome of Pregnancy, Am. J. Clin. Nutr. 71, 1295S-1303S.
Aubard, Y., Darodes, N., and Cantaloube, M. (2000) Hyperhomocysteinemia and Pregnancy—Review of Our Present Understanding and Therapeutic Implications, Eur. J. Obstet. Gynecol. Reprod. Biol. 93, 157–165.
Nygård, O., Nordrehaug, J.E., Refsum, H., Ueland, P.M., Farstad, M., and Vollset, S.E. (1997) Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease, N. Engl. J. Med. 337, 230–236.
McKinley, M.C. (2000) Nutritional Aspects and Possible Pathological Mechanisms of Hyperhomocysteinaemia: An Independent Risk Factor for Vascular Disease, Proc. Nutr. Soc. 59, 221–237.
Anderson, J.L., Muhlestein, J.B., Horne, B.D., Carlquist, J.F., Bair, T.L., Madsen, T.E., and Pearson, R.R. (2000) Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients with Angiographically Defined Coronary Artery Disease, Circulation 102, 1227–1232.
Aronow, W.S., and Ahn, C. (2000) Increased Plasma Homocysteine Is an Independent Predictor of New Coronary Events in Older Persons, Am. J. Cardiol. 86, 346–347.
Aronow, W.S., Ahn, C., and Gustein, H. (2000) Increased Plasma Homocysteine Is an Independent Predictor of New Atherothrombotic Brain Infarction in Older Persons, Am. J. Cardiol. 86, 585–586.
Ducloux, D., Motte, G., Challier, B., Gibey, R., and Chalopin, J.M. (2000) Serum Total Homocysteine and Cardiovascular Disease Occurrence in Chronic, Stable Renal Transplant Recipients: A Prospective Study, J. Am. Soc. Nephrol. 11, 134–137.
Hoogeveen, E.K., Kostense, P.J., Jakobs, C., Dekker, J.M., Nijpels, G., Heine, R.J., Bouter, L.M., and Stehouwer, C.D. (2000) Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes: 5-Year Follow-up of the Hoorn Study, Circulation 101, 1506–1511.
Kark, J.D., Selhub, J., Bostom, A., Adler, B., and Rosenberg, I.H. (1999) Plasma Homocysteine and All-Cause Mortality in Diabetes [Letter], Lancet 353, 1936–1937.
Miner, S.E., Hegele, R.A., Sparkes, J., Teilel, J.M., Bowman, K.A., Connelly, P.W., Banijamali, H., Lau, H.K., Chisholm, R.J., Babaei, S., and Strauss, B.H. (2000) Homocysteine, Lipoprotein(a), and Restenosis After Percutaneous Transluminal Coronary Angioplasty: A Prospective Study, Am. Heart J. 140, 272–278.
Ridker, P.M., Hennekens, C.H., Buring, L.E., and Rifai, N. (2000) C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women, N. Engl. J. Med. 342, 836–843.
Shemin, D., Lapane, K.L., Bausserman, L., Kanaan, E., Kahn, S., Dworkin, L., and Bostom, A.G. (1999) Plasma Total Homocysteine and Hemodialysis Access Thrombosis: A Prospective Study, J. Am. Soc. Nephrol. 10, 1095–1099.
Suliman, M.E., Qureshi, A.R., Barany, P., Stenvinkel, P., Filho, J.C., Anderstam, B., Heimburger, O., Lindholm, B., and Bergstrom, T. (2000) Hyperhomocysteinemia, Nutritional Status, and Cardiovascular Disease in Hemodialysis Patients, Kidney Int. 57, 1727–1735.
Voutilainen, S., Lakka, T.A., Hamelahti, P., Lehtimaki, T., Poulsen, H.E., and Salonen, J.T. (2000) Plasma Total Homocysteine Concentration and the Risk of Acute Coronary Events: the Kuopio Ischaemic Heart Disease Risk Factor Study, J. Intern. Med. 248, 217–222.
Ueland, P.M., Refsum, H., Beresford, S.A., and Vollset, S.E. (2000) The Controversy over Homocysteine and Cardiovascular Risk, Am. J. Clin. Nutr. 72, 324–332.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ueland, P.M., Nygård, O., Vollset, S.E. et al. The Hordaland Homocysteine Studies. Lipids 36 (Suppl 1), S33–S39 (2001). https://doi.org/10.1007/s11745-001-0679-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-001-0679-7